Venture Planning Group Research

Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the healthcare, biotechnology, chemical, food and beverage, electronics, and other industries.

The company’s services include:
  • Market Intelligence Surveys
  • Opportunities Analyses
  • New Technology/Product Assessments
  • Acquisitions/Joint Venture Evaluations
During the course of numerous proprietary single-client consulting assi
gnments and over 100 multi-client studies, VPG has developed an extensive database on various industries, technologies, markets, companies, products, and executives worldwide.

VPG has served over 1,000 corporations in 70 countries, and has established a broad network of domestic and international contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government.
Venture Planning Group Research
 

List of reports from Venture Planning Group Research

< prev 1    3  4  5  6  7  8  9  10  
Analogic: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector
8/11/2014 | published by: Venture Planning Group
... insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global ...  |  read more...
USD 2,450
The 2014 World's Leading Diagnostic Imaging Companies
8/7/2014 | published by: Venture Planning Group
... diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, marketing and R&D programs. The study’s major objectives include: To establish a comprehensive, factual, ...  |  read more...
USD 14,500
Hitachi: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector
8/7/2014 | published by: Venture Planning Group
... insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global ...  |  read more...
USD 2,450
Toshiba: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector
8/7/2014 | published by: Venture Planning Group
... insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global ...  |  read more...
USD 2,450
Philips: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector
8/7/2014 | published by: Venture Planning Group
... insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global ...  |  read more...
USD 2,450
USD 2,450
Esaote: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector
8/7/2014 | published by: Venture Planning Group
... insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global ...  |  read more...
USD 2,450
Shimadzu: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector
8/7/2014 | published by: Venture Planning Group
... insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global ...  |  read more...
USD 2,450
Hologic: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector
8/7/2014 | published by: Venture Planning Group
... insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global ...  |  read more...
USD 2,450
Siemens: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector
8/7/2014 | published by: Venture Planning Group
... insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global ...  |  read more...
USD 2,450
The 2014 Global Ultrasound Market: Strategic Assessments of Leading Suppliers
8/7/2014 | published by: Venture Planning Group
... designed to provide diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, marketing and R&D programs. The study’s major objectives include: To establish ...  |  read more...
USD 12,500
GE: Global Challenges, Technological Capabilities, Marketing Tactics, and Strategic Direction in the Diagnostic Imaging Sector
8/7/2014 | published by: Venture Planning Group
... insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global ...  |  read more...
USD 2,450
Zimmer - Organization, Facilities, Technologies, Products, Marketing, R&D, Strategies
7/29/2014 | published by: Venture Planning Group
... of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global orthopedics market. Contains 30 pages Please note: The delivery time for the ...  |  read more...
USD 1,850
US Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
7/29/2014 | published by: Venture Planning Group
... This new study from Venture Planning Groupcontains 636 pages, 27 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnosticsmarket during the ...  |  read more...
USD 6,200
Wright Medical - Organization, Technologies, Products, Marketing, R&D, Strategies
7/28/2014 | published by: Venture Planning Group
... implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global orthopedics market. Contains 30 pages Please note: The delivery time for ...  |  read more...
USD 1,850
UK Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
7/28/2014 | published by: Venture Planning Group
... market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnosticsmarket during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts ...  |  read more...
USD 4,350
2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals and Commercial Labs
7/27/2014 | published by: Venture Planning Group
... be custom-tailored to your specific information needs and budget. “ 2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs ” is Venture ...  |  read more...
USD 6,700
2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals and Commercial Labs
7/27/2014 | published by: Venture Planning Group
... be custom-tailored to your specific information needs and budget. “ 2014 Market Segmentation Analysisof the ItalianCancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs ” is Venture Planning Group’s ...  |  read more...
USD 6,700
2014 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals and Commercial Labs
7/27/2014 | published by: Venture Planning Group
... be custom-tailored to your specific information needs and budget. “ 2014 Market Segmentation Analysisof the SpanishCancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs ” is Venture Planning Group’s ...  |  read more...
USD 6,700
2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals, Commercial Labs, POC Locations
7/27/2014 | published by: Venture Planning Group
... can be custom-tailored to your specific information needs and budget. “ 2014 Market Segmentation Analysisof the USCancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations ” is Venture ...  |  read more...
USD 9,800
Stryker - Organization, Facilities, Technologies, Products, Marketing, R&D, Strategies
7/27/2014 | published by: Venture Planning Group
... of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global orthopedics market. Contains 35 pages Please note: The delivery time for the ...  |  read more...
USD 1,850
Spain Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
7/27/2014 | published by: Venture Planning Group
... This new study from Venture Planning Groupcontains 610 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnosticsmarket during the ...  |  read more...
USD 4,350
2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals, Commercial Labs, POC Locations
7/27/2014 | published by: Venture Planning Group
... and can be custom-tailored to your specific information needs and budget. “ 2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations ...  |  read more...
USD 34,500
2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals, Commercial Labs, POC Locations
7/27/2014 | published by: Venture Planning Group
... and can be custom-tailored to your specific information needs and budget. “ 2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations ...  |  read more...
USD 19,700
2014 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals, Commercial Labs and Physician Offices
7/27/2014 | published by: Venture Planning Group
... and can be custom-tailored to your specific information needs and budget. “ 2014 Market Segmentation Analysisof the GermanCancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, and Physician Offices ” ...  |  read more...
USD 6,700
< prev 1    3  4  5  6  7  8  9  10  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!